Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2022

Stockholders' Equity Note [Abstract]

Schedule of preferred stock dividend declaration and payment

The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2022 through March 31, 2022:

Declaration Date	Record Date	Payment Date	Dividend Per Share
February 17, 2022	March 1, 2022	March 31, 2022	$0.46875

The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2022 through March 31, 2022:

Declaration Date	Record Date	Payment Date	Dividend Per Share
February 17, 2022	March 1, 2022	March 31, 2022	$0.40625

Schedule of common stock dividend declaration and payment

The following table presents cash dividends declared by the Company on its common stock from January 1, 2022 through March 31, 2022:

Declaration Date	Record Date	Payment Date	Dividend Per Share
March 11, 2022	March 22, 2022	April 29, 2022	$0.110	(1)

(1) At March 31, 2022, the Company had accrued dividends and dividend equivalents payable of $46.4 million related to the common stock dividend declared on March 11, 2022 The $0.11 per share dividend paid was based on the number of shares held by stockholders at the record date (March 22, 2022) and before giving effect to the Company’s 1-for-4 reverse stock split effected on April 4, 2022).

Schedule of changes in balances of each component of the entity's AOCI

The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2022:

	Three Months Ended March 31, 2022
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net Unrealized Gain/(Loss) on Financing Agreements (1)		Total  AOCI
Balance at beginning of period	$	46,833	$	(1,255)	$	45,578
OCI before reclassifications	(4,977)		1,255		(3,722)
Amounts reclassified from AOCI	—		—		—
Net OCI during the period (2)	(4,977)		1,255		(3,722)
Balance at end of period	$	41,856	$	—	$	41,856

(1)Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.

(2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).

The following table presents changes in the balances of each component of the Company’s AOCI for the three months ended March 31, 2021:

	Three Months Ended March 31, 2021
(In Thousands)	Net Unrealized Gain/(Loss) on AFS Securities		Net Unrealized Gain/(Loss) on Financing Agreements (1)		Total AOCI
Balance at beginning of period	$	79,607	$	(2,314)	$	77,293
OCI before reclassifications	(3,855)		235		(3,620)
Amounts reclassified from AOCI	—		—		—
Net OCI during the period (2)	(3,855)		235		(3,620)
Balance at end of period	$	75,752	$	(2,079)	$	73,673

(1)  Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.

(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).